2387402-80-2

EZH2-IN-11 is a potent inhibitor of E2HZ. The oncogenic activities of EZH2 have been shown by a number of studies in various different cancer types. EZH2-IN-11 has the potential for the research of cancer diseases (extracted from patent WO2019204490A1, compound 17)[1].

[1] Alexandre C?té, et al. Modulators of methyl modifying enzymes, compositions and uses thereof. Patent WO2019204490A1.